• P2RX1, CaMKII, and Mitochondrial Apoptosis in Ph+ ALL

  2026-10-06

  Li et al. report that P2RX1 overexpression increases tyrosine kinase inhibitor-associated mitochondrial apoptosis in Ph+ acute lymphoblastic leukemia cells through calcium dysregulation, CaMKII activation, and PI3K/Akt suppression. The study offers a mechanistic framework for understanding treatment sensitivity, while its single-cell-line design and database associations limit direct clinical translation.

• Liposomal Ce6-PDT, Pyroptosis, and Tumor Immunity

  2026-10-05

  A 2024 study reports that liposomal chlorin e6 photodynamic therapy links mitochondrial oxidative damage to caspase-1-associated pyroptosis in breast cancer models. The findings also connect this inflammatory cell-death pathway with immunogenic cell death and improved antitumor effects when combined with immune checkpoint inhibition, while remaining limited to preclinical evidence.

• Docetaxel (Taxotere): Mechanism and Evidence

  2026-10-05

  Docetaxel, also known as Taxotere, is a taxane that stabilizes microtubules and disrupts mitotic progression. Its research value is strongest when cytostatic effects, apoptosis, model context, and tumor-biology variables are interpreted as separate evidence streams.

• HMGCS2, LysoPC, and Pulmonary Fibrosis

  2026-10-04

  Yang et al. report that injured type II alveolar epithelial cells are a major source of accumulated lysophosphatidylcholines in experimental pulmonary fibrosis, linking epithelial lipid dysregulation to fibroblast activation. Their data support an HMGCS2–PPARα–CPT1A/CPT2 axis that influences lipid handling and disease progression, while leaving the contribution of individual LysoPC species and relevance to human disease open for further study.

• SR-202 and PPARγ: Evidence in IBD Research

  2026-10-03

  A source-grounded overview of SR-202 as a selective PPARγ antagonist, examining its reported role in octanoic acid-rich nutrition research, implications for macrophage biology and metabolic disease studies, and the limits of translating preclinical pathway evidence into clinical conclusions.

• Anti-Diabetic Drugs and Weight Loss in T2D

  2026-10-02

  This review organizes non-insulin glucose-lowering drugs by their observed weight-loss effects in patients with type 2 diabetes, linking pharmacological class with clinically relevant changes in body weight, BMI, and body composition. Its central finding is that weight reduction varies substantially across agents: ertugliflozin belongs to a moderate weight-loss group, whereas several GLP-1 receptor agonists produce larger average reductions.

• CLK2 and Platinum Resistance in Ovarian Cancer

  2026-10-01

  The reference study identifies Cdc2-like kinase 2 (CLK2) as a determinant of platinum resistance in ovarian cancer and links this phenotype to phosphorylation of BRCA1 at Ser1423. Its integrated tissue, cellular, mechanistic, and xenograft evidence suggests that CLK2 supports DNA damage repair and may provide a target for resistance-oriented research.

• Tomivosertib: Translating MNK–eIF4E Biology

  2026-10-01

  Tomivosertib offers translational researchers a selective way to interrogate MNK1/2-dependent eIF4E phosphorylation and connect pathway inhibition with functional outcomes in acute myeloid leukemia and other disease models. This thought-leadership analysis converts mechanistic evidence into practical study-design and biomarker strategies.

• Potassium Iodide (KI): Mechanism and Research Use

  2026-09-30

  Potassium Iodide (KI) is a water-soluble inorganic iodide source used in thyroid-related research and radioactive iodine thyroid blocking contexts. Its research value depends on controlled iodide delivery, documented solvent compatibility, prompt solution use, and strict separation from clinical instructions.

• Shufeng Xingbi Therapy in Allergic Rhinitis Rats

  2026-09-30

  This preprint examines how Shufeng Xingbi Therapy affects allergic rhinitis in rats by integrating nasal immune readouts with intestinal microbiota and short-chain fatty acid measurements. The findings support a microbiota-associated mechanism involving reduced IgE and IL-4, altered bacterial composition, increased SCFAs, and suppression of STAT5, STAT6, and GATA3 signaling, while leaving important questions about causality and clinical translation.

• WZ4003: Practical NUAK1/2 Inhibitor Workflows

  2026-09-29

  WZ4003 is a selective NUAK1/2 inhibitor for connecting kinase target engagement with cell migration, proliferation, invasion, and tau-phosphorylation phenotypes. This workflow-focused guide shows how to validate specificity, build dose–response experiments, and interpret differences between cancer models and ex vivo brain tissue.

• Coumestrol C5832: Reliable Cell Assay Workflows

  2026-09-29

  Learn how Coumestrol SKU C5832 can improve interpretation and reproducibility in cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide connects formulation, receptor pharmacology, ferroptosis evidence, and practical assay controls.

• Brain-to-Spinal Control of Opioid Hypersensitivity

  2026-09-28

  Yin et al. identify a lateral parabrachial–hypothalamic–spinal opioid pathway that controls morphine-induced mechanical hypersensitivity and analgesic tolerance in mice. The work separates mechanical opioid pain effects from better-established thermal mechanisms and provides a circuit framework for targeted pain mechanism research.

• Optimizing iPSC-Derived Functional Platelet Production

  2026-09-28

  A 2026 study presents an optimized embryoid-body protocol for producing megakaryocytes and functional platelets from human induced pluripotent stem cells. By adjusting starting cell input, medium composition, differentiation cues, and megakaryocyte maturation, the approach shortened production to 19 days, increased reported yields, and reduced costs.

• Sex Differences in Angiotensin II Hypertension in Mice

  2026-09-27

  Using telemetry in conscious mice, Xue and colleagues found that chronic angiotensin II produced a substantially larger blood-pressure increase in males than in females, while gonadectomy shifted the response in opposite directions by sex. The study also linked the male response to altered baroreflex control and a larger blood-pressure fall during ganglionic blockade, offering a framework for investigating sex-dependent autonomic contributions to hypertension.

7944 records 5/530 page Previous Next 12345 下5页 Last page